Hepatitis: Clinical Trials

52 trials for Hepatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

52 terminated. 52 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 352Terminated 52
Phase 25Terminated 5

Follow Hepatitis: new trials by email Literature Review of Hepatitis trials Research Report on Hepatitis

Trials (filtered) newest first · largest first

All 52 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
Best Practice, Entecavir, Tenofovir Alafenamide - Hepatitis B Infection, Malignant Solid Neoplasm
Phase 3TerminatedSWOG Cancer Research Network42020-01-172024-05-20
A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection
No Treatment - Hepatitis C
Phase 3TerminatedJanssen Research & Development, LLC242017-04-102025-02-03
Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies
LDV/SOF, RBV - Hepatitis C Virus Infection
Phase 3TerminatedGilead Sciences872015-11-112018-11-16
Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Steroid
G-CSF (Filgrastim injection), steroid, placebo - Alcoholic Hepatitis
Phase 3TerminatedChuncheon Sacred Heart Hospital642015-07-012022-08-08
Primary Prevention Hepatocellular Carcinoma by Metformin
Metformin, placebo tablet - Hepatocellular Carcinoma, Hepatitis C, Chronic
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris112015-06-012017-01-11
Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis
Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV) - Hepatitis C
Phase 3TerminatedUniversity of Colorado, Denver92015-05-012021-09-13
Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection
Telbivudine, Placebo - Chronic Hepatitis B
Phase 3TerminatedNovartis Pharmaceuticals532014-10-312019-09-10
To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure
ELAD, Standard of Care treatment - Severe Acute Alcoholic Hepatitis
Phase 3TerminatedVital Therapies, Inc.182014-04-012019-02-19
A Health Intervention to Prevent Depression Hepatitis C Patients
Exercise, Health Education - Hepatitis C, Major Depressive Disorder
Phase 2 / Phase 3TerminatedUniversity of Texas Southwestern Medical Center12013-06-012016-12-29
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
Pegylated Interferon Alfa 2a, Ribavirin, Telaprevir - Infection
Phase 3TerminatedM.D. Anderson Cancer Center12013-04-012020-09-24
Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C
Eltrombopag - Thrombocytopenia, Hepatitis C
Phase 2 / Phase 3TerminatedUniversity of Texas Southwestern Medical Center72013-04-012019-11-13
HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin
boceprevir, Ribavirin, Peginterferon alfa-2a - Hepatitis C, HIV Infections
Phase 3TerminatedAnna Cruceta1082013-03-102025-08-24
A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450)
PEG-Intron™, PEGASYS™ - Hepatitis B, Chronic
Phase 3TerminatedMerck Sharp & Dohme LLC4022012-11-262018-08-27
3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study
Previous treatment in DEB025 study - Hepatitis C, Chronic
Phase 3TerminatedNovartis Pharmaceuticals1052012-09-062018-01-12
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma
Tenofovir, Placebo - Chronic Hepatitis B, Hepatocellular Carcinoma
Phase 3TerminatedTaichung Veterans General Hospital3202012-09-012014-09-04
Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
Entecavir, Placebo - Chronic Hepatitis B, Rheumatoid Arthritis
Phase 3TerminatedSeoul National University Hospital432012-09-012017-03-06
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
Entecavir and peginterferon - Hepatitis B
Phase 3TerminatedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)282012-05-012022-05-26
Long Term Vitamin D Therapy in HCV Treated Patients
Vitamin D - Chronic Hepatitis C
Phase 3TerminatedDr. Nadia AbdelAaty AbdelKader1002012-04-012013-11-28
Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C
Alisporivir, Peginterferon alfa-2a, Ribavirin - Hepatitis C
Phase 3TerminatedDebiopharm International SA62012-03-012016-08-01
Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1
Alisporivir, Boceprevir, Peginterferon alfa-2a - Hepatitis C
Phase 3TerminatedDebiopharm International SA82011-12-012017-01-16

Showing 20 of 52. Sign in to see all of them.

Narrower conditions

Hepatitis C (19)  ·  Hepatitis C, Chronic (18)  ·  Hepatitis B (15)  ·  Hepatitis B, Chronic (7)  ·  Carcinoma, Hepatocellular (4)  ·  HIV Infections (4)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Hepatitis, Alcoholic (2)  ·  Hepatitis, Chronic (2)  ·  Liver Cirrhosis (2)  ·  Liver Diseases (2)  ·  Thrombocytopenia (2)  ·  Arthritis, Juvenile (1)  ·  Arthritis, Psoriatic (1)

Broader conditions

Digestive System Diseases (52)  ·  Liver Diseases (50)  ·  Hepatitis, Viral, Human (49)  ·  Virus Diseases (49)  ·  Blood-Borne Infections (48)  ·  Communicable Diseases (48)  ·  Infections (48)  ·  RNA Virus Infections (32)  ·  Flaviviridae Infections (30)  ·  Disease Attributes (28)  ·  Pathologic Processes (28)  ·  Pathological Conditions, Signs and Symptoms (28)  ·  Chronic Disease (27)  ·  Hepatitis, Chronic (25)

Interventions

Ribavirin (17)  ·  peginterferon alfa-2a (12)  ·  peginterferon alfa-2b (9)  ·  clevudine (6)  ·  Tenofovir (5)  ·  entecavir (4)  ·  N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide (3)  ·  Telbivudine (3)  ·  adefovir (3)  ·  telaprevir (3)  ·  alisporivir (2)  ·  eltrombopag (2)  ·  Amantadine (1)  ·  Antiretroviral Therapy, Highly Active (1)  ·  Blood Specimen Collection (1)

Sponsors

Merck Sharp & Dohme LLC (6)  ·  French National Agency for Research on AIDS and Viral Hepatitis (5)  ·  Bukwang Pharmaceutical (3)  ·  GlaxoSmithKline (3)  ·  Novartis Pharmaceuticals (3)  ·  Debiopharm International SA (2)  ·  Novartis (2)  ·  Pharmasset (2)  ·  University Health Network, Toronto (2)  ·  University of Texas Southwestern Medical Center (2)  ·  Vertex Pharmaceuticals Incorporated (2)  ·  Anna Cruceta (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bristol-Myers Squibb (1)  ·  Chuncheon Sacred Heart Hospital (1)

Countries

United States (19)  ·  Canada (12)  ·  South Korea (9)  ·  France (8)  ·  Spain (8)  ·  Germany (7)  ·  Puerto Rico (6)  ·  Taiwan (6)  ·  Poland (5)  ·  Belgium (4)  ·  Italy (4)  ·  Thailand (4)  ·  United Kingdom (4)  ·  Argentina (3)  ·  Australia (3)

Top investigators

Hyo-Suk Lee, MD. PhD (3)  ·  Alexander Kuo, MD (1)  ·  Amanda Wieland, MD (1)  ·  Amany Y Elkazaz (1)  ·  Andres Duarte-Rojo, MD (1)  ·  Anita Rachlis, MD (1)  ·  Anna Lok, MD (1)  ·  Anne M Larson, MD (1)  ·  Anupama Duddempudi, MD (1)  ·  Averell Sherker, MD (1)  ·  Benoit Trottier, MD (1)

Results publications

PMID 17593061, PMID 17635375, PMID 17647293, PMID 17850410, PMID 18266997, PMID 19053983, PMID 22913681, PMID 25009371, PMID 25152207, PMID 27219495, PMID 29091342, PMID 30577864, PMID 8213790, PMID 9346731

NIH funding

2008 (2), 2005 (1), 2016 (1), M01RR000040 (1), P30DK050306 (1), U01DK082843 (1), U01DK082863 (1), U01DK082864 (1), U01DK082866 (1), U01DK082867 (1), U01DK082871 (1), U01DK082872 (1), U01DK082874 (1), U01DK082916 (1), U01DK082919 (1)